License Grants and Intellectual Property. (A) Subject to Tanox’s compliance with the applicable surviving terms and conditions of this Agreement as set forth in this Part 1 of Schedule D and in Section 18.4(d) and Section 18.6, Tanox shall have an exclusive (as to Anti-IgE Antibodies and Anti-IgE Products), Worldwide license (which shall include the right to grant sublicenses) from the Terminating Party(ies) to develop, make, have made (in the case of making and having made, subject to paragraph (vii) below), use, import, offer to sell and sell Anti-IgE Products and Anti-IgE Antibodies under the Anti-IgE Patents, Company Information and Know-How Controlled by the Terminating Party(ies) existing at the effective date of termination, which Anti-IgE Patents, Company Information and Know-How are reasonably required, or to the extent they are used by the Terminating Party(ies) or its (or their) licensee or sublicensee as at the effective date of termination, to Develop, make, have made, use, import, offer to sell and sell Active Products. The foregoing license:
License Grants and Intellectual Property. A Subject to the applicable Assignee’s compliance with the applicable surviving terms and conditions of this Agreement as set forth in this Part 3 of Schedule D and Section 18.6 of this Agreement, the applicable Assignee shall have an exclusive (as SCHEDULE D to Anti-IgE Antibodies and Anti-IgE Products) license (which shall include the right to grant sublicenses) from Novartis in the applicable regions to develop, make, have made (in the case of making and having made, subject to paragraph vii below), use, import, offer to sell and sell Anti-IgE Products and Anti-IgE Antibodies under the Anti-IgE Patents, Company Information and Know-How Controlled by Novartis existing at the effective date of Novartis’ termination which Anti-IgE Patents, Company Information and Know-How are reasonably required, or to the extent they are used by a Party or its licensee or sublicensee as at the effective date of termination, to Develop, make, have made, use, import, offer to sell and sell Active Products. The foregoing license:
License Grants and Intellectual Property. 4.1 Subject to the terms and conditions of this Agreement, Vendor grants to immixTechnology a non-exclusive license during the term of this Agreement to use Vendor’s logos and trademarks associated with the Products (“Trademarks”) to promote and market the Products to Government Customers, provided that immixTechnology’s use of the Trademarks is in accordance with Vendor’s then-current trademark usage guidelines. immixTechnology acknowledges and agrees that Vendor owns the Trademarks and that any and all goodwill derived from the use of the Trademarks by immixTechnology hereunder inures solely to the benefit of Vendor. immixTechnology hereby assigns to Vendor all right, title and interest in the Trademarks, together with the goodwill attaching thereto, that may inure to it in connection with this Agreement or from its use of the Trademarks hereunder. immixTechnology will at no time contest or aid in contesting the validity or ownership of any Trademark or take any action in derogation of Vendor’s rights therein, including without limitation applying to register any trademark, trade name, service xxxx or other designation that is confusingly similar to any Trademark. immixTechnology agrees not to attach any additional trademarks, trade names, logos or designations to any Product.
License Grants and Intellectual Property
